HIGHRegulatoryTier 1
BAXTER ISSUES VOLUNTARY NATIONWIDE RECALL OF CEFAZOLIN IN DEXTROSE INJECTION, USP, 2G / 100ML (20MG / ML) SINGLE-DOSE INFUSION BAG IN 100ML DUE TO PARTICULATE MATTER FOUND IN SOLUTION
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
Dental clinics that administer or dispense IV cefazolin (pre-op prophylaxis, odontogenic infections, or implant cases) face immediate supply disruption and potential patient-safety liability if the recalled lot is in inventory.
Key points
- Lot LD175708, Exp 14-Feb-2027, single-dose 2 g/100 mL bags are subject to the nationwide recall; any unused stock must be quarantined and returned.
- Particulate (cardboard) in IV bags creates risk of embolism or phlebitis if infused; oral surgeons and implant dentists who stock this product must verify lot numbers immediately.
- Cefazolin is a first-line antibiotic for beta-lactam-sensitive patients undergoing dento-alveolar surgery; substitution may affect resistance profiles or require ID consult.
- DSOs and multi-site practices should audit central pharmacies and ambulatory surgery centers for this lot to avoid CMS/State survey citations for recalled medications.
Who should care
OwnerDSOSpecialist
Read the original on FDA Recalls
Full reporting and any paywall content live on fda.gov. We summarize and score; we do not republish.